新城發展(01030.HK):擬發行將由公司擔保的優先綠色票據
格隆匯5月30日丨新城發展(01030.HK)發佈公吿,發行人(公司子公司)擬進行國際性票據發售。票據擬由公司擔保。票據的定價,包括本金總額、發售價及利率將由獨家全球協調人、聯席賬簿管理人及聯席牽頭經辦人透過使用入標定價的方式釐定。除非按票據條款提前贖回或購回,票據(如發行)將須於到期日償還。
於該公吿日期,建議票據發行的金額、條款及條件尚待釐定。在票據條款落實後,獨家全球協調人、聯席賬簿管理人及聯席牽頭經辦人、發行人與公司預期將訂立購買協議,據此,獨家全球協調人、聯席賬簿管理人及聯席牽頭經辦人將為票據的初始買方。倘簽訂購買協議,公司將就建議票據發行另行刊發公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.